Nurix Therapeutics shares are trading lower after the company priced an upsized public offering of 10,166,667 shares of common stock at $15 per share.
Portfolio Pulse from Benzinga Newsdesk
Nurix Therapeutics' stock price is trading lower following the announcement of an upsized public offering of 10,166,667 shares at $15 each.
April 12, 2024 | 1:23 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Nurix Therapeutics' shares are trading lower due to the pricing of an upsized public offering.
The announcement of an upsized public offering typically leads to a decrease in stock price due to the dilution of existing shares. In this case, Nurix Therapeutics' decision to increase the size of its public offering and price it at $15 per share has led to a negative short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100